Join to View Full Profile
Ccr 10 Center Drive Room 6n110Bethesda, MD 20892
Phone+1 301-451-9018
Dr. Ramaswami is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Imperial College London School of MedicineClass of 2007
Certifications & Licensure
ME State Medical License 2020 - 2026
Clinical Trials
- NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma Start of enrollment: 2020 Jul 13
- NT-I7 for Kaposi Sarcoma in Patients With or Without HIV Start of enrollment: 2022 May 23
- Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma Start of enrollment: 2016 Jan 13
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- When cytokine storms collide: understanding hemophagocytic lymphohistiocytosis in human herpesvirus 8/Kaposi sarcoma herpesvirus-associated multicentric Castleman dise...Ramya Ramaswami, Theodoros Kelesidis, James J Goedert
AIDS. 2025-04-01 - The elevated expression of ORF75, a KSHV lytic gene, in Kaposi sarcoma lesions is driven by a GC-rich DNA cis element in its promoter region.Ashwin Nair, David A Davis, Andrew Warner, Baktiar Karim, Ramya Ramaswami
Plos Pathogens. 2025-03-17 - Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion Lymphoma.Kathryn Lurain, Ramya Ramaswami, Eric Oksenhendler, David Boutboul, Alessia Dalla Pria
American Journal of Hematology. 2025-03-01
Journal Articles
- Discovery of Kaposi’s Sarcoma Herpesvirus-Encoded Circular RNAs and a Human Antiviral Circular RNARamya Ramaswami, Kathryn Lurain, Thomas S Uldrick, Proceedings of the National Academy of Sciences
Press Mentions
HIV-Associated Cancers and Lymphoproliferative Disorders Caused by Kaposi Sarcoma Herpesvirus and Epstein-Barr VirusJune 25th, 2024
Grant Support
- Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman diseaseDIVISION OF BASIC SCIENCES - NCIPresent
- Targeted therapies for Kaposi sarcoma and KSHV-multicentric Castleman diseaseDIVISION OF BASIC SCIENCES - NCIPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
